Group B Streptococcus GBS Diagnosis Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)
Group B Streptococcus (GBS) Diagnosis Market is segmented By Diagnostic Method (Culture Test, PCR Testing, Serological Testing), By Treatment Type (An....
Competitive overview of Group B Streptococcus GBS Diagnosis Market
The major players operating in the Group B Streptococcus (GBS) Diagnosis Market include Pfizer Inc., Novartis AG, Merck & Co., Inc., GlaxoSmithKline plc, Sanofi, Abbott Laboratories, and Johnson & Johnson.
Group B Streptococcus GBS Diagnosis Market Leaders
- Pfizer Inc.
- Novartis AG
- Merck & Co., Inc.
- GlaxoSmithKline plc
- Sanofi
*Disclaimer: Major players are listed in no particular order.
Group B Streptococcus GBS Diagnosis Market - Competitive Rivalry
Group B Streptococcus GBS Diagnosis Market
Market Consolidated
(Dominated by major players)
(Dominated by major players)
Market Fragmented
(Highly competitive with lots of players.)
(Highly competitive with lots of players.)
*Source: Coherent Market Insights